Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] by John G.F. Cleland, Jean-Claude Daubert, Erland Erdmann, Nick Freemantle, Daniel Gras, Lukas Kappenberger, and Luigi Tavazzi EHJ Volume 27(16): August 2, 2006 © The European Society of Cardiology All rights reserved. For Permissions, please
The Kaplan–Meier estimates of the time to all-cause mortality. John G.F. Cleland et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please
John G.F. Cleland et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please
John G.F. Cleland et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please
Effect of cardiac resynchronization on all-cause mortality in subgroups pre-defined by the main study analysis. John G.F. Cleland et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please